Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Reporting results of cancer treatment

1981 • 7,916 citations

Promotion of microtubule assembly in vitro by taxol

1979 • 3,521 citations

Taxol stabilizes microtubules in mouse fibroblast cells.

1980 • 1,942 citations

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

1982 • 987 citations

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1991 • 668 citations

Relationships between the structure of taxol analogs and their antimitotic activity

1991 • 538 citations

Highly efficient, practical approach to natural taxol

1988 • 531 citations

Taxol: an antimitotic agent with a new mechanism of action

1984 • 483 citations

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

1991 • 480 citations

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

1993 • 441 citations

Chemotherapy of Lung Cancer

1992 • 434 citations

Taxol-induced polymerization of purified tubulin. Mechanism of action.

1981 • 407 citations

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

1993 • 346 citations

The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)

1993 • 281 citations

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.

1993 • 253 citations

Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues

1989 • 156 citations

Coping with toxicities of docetaxel (TaxotereTM)

1993 • 145 citations

Phase I Trial of Taxotere: Five-Day Schedule

1992 • 136 citations

Interactions of taxol, microtubule-associated proteins, and guanine nucleotides in tubulin polymerization.

1981 • 114 citations

Chemotherapy for unresectable non-small cell lung cancer

1991 • 42 citations